Evotec AG
Schnackenburgalle 114
Hamburg
22525
Germany
Tel: 49-40-560810
Fax: 49-40-56081222
Website: http://www.evotec.de/
Email: info@evotecoai.com
574 articles about Evotec AG
-
Evotec AG Reports Start of Phase II Proof-of-Concept Quit Rate Study with EVT 302 and Results of Craving Study
9/11/2008
-
Evotec AG and Boehringer Ingelheim Corporation Achieve Milestone in Joint Discovery Collaboration
9/2/2008
-
Evotec AG Reports Results of the First Half of 2008
8/6/2008
-
Evotec AG to Report First Half 2008 Results on August 6, 2008
8/1/2008
-
Evotec AG Announces Initiation of Phase I Clinical Trial of VR1 Antagonist Under Partnership With Pfizer Inc.
8/1/2008
-
Evotec AG's EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study
7/3/2008
-
Evotec AG Reports First Quarter 2008 Result
5/8/2008
-
Evotec AG to Report First Quarter Results on May 8, 2008
5/6/2008
-
Evotec AG Completes Acquisition of Renovis, Inc.
5/5/2008
-
Renovis, Inc. Stockholders Approve Acquisition by Evotec AG
5/1/2008
-
Renovis, Inc. Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec AG on Track to Close in Early May, 2008
4/4/2008
-
Evotec AG's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks Single-Dose, Volunteer fMRI Study Completed and Reported Today Dosing in Four Week Higher Repeat Dose Study Completed
3/28/2008
-
Evotec AG Announces Financial Results for 2007
3/28/2008
-
Ono Pharmaceutical Company, Ltd. Enters into a New Fragment-Based Drug Discovery Agreement with Evotec AG Up to Three-Year Integrated Drug Discovery Support Program
3/27/2008
-
Evotec AG's Registration Statement in Connection With its Proposed Acquisition of Renovis, Inc. Declared Effective
3/26/2008
-
Evotec AG Fiscal Year 2007 Results Presentation on March 28, 2008 Live on the Internet
3/20/2008
-
Spermatech Selects Evotec AG as Partner for High-Throughput Screening and Lead Discovery
3/12/2008
-
Evotec AG Expands Collaboration With InterMune, Inc.
3/6/2008
-
Evotec AG Starts Phase II in Smoking Cessation with EVT 302
2/28/2008
-
Evotec AG Extends Ongoing Collaboration With CHDI Worth up to US $37M
2/14/2008